Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring

BACKGROUND: Direct-acting antiviral agents (DAAs) cure patients with hepatitis C virus (HCV) infection. Concerns have arisen the occurrence of significant bradyarrhythmias during treatment with DAAs. The aim of this study was to assess the impact of a DAA combination for the treatment of HCV infecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Egypt Heart J
Main Authors: El Missiri, Ahmed Mohamed, Rayan, Mona Mostafa, Awad, Mohamed Medhat, El Desoky, Ahmed Ibrahim
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7329943/
https://ncbi.nlm.nih.gov/pubmed/32613565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s43044-020-00070-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados